{
    "organizations": [],
    "uuid": "db9faff4ae9e1347d205e9d714228948fc1b1846",
    "author": "",
    "url": "https://www.reuters.com/article/brief-juniper-pharmaceuticals-outlines-s/brief-juniper-pharmaceuticals-outlines-strategic-priorities-for-2018-and-reports-recent-portfolio-progress-idUSFWN1OX0NS",
    "ord_in_thread": 0,
    "title": "BRIEF-Juniper Pharmaceuticals Outlines Strategic Priorities For 2018 And Reports Recent Portfolio Progress",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": " 11 PM / Updated 7 minutes ago BRIEF-Juniper Pharmaceuticals Outlines Strategic Priorities For 2018 And Reports Recent Portfolio Progress Reuters Staff \nJan 2 (Reuters) - Juniper Pharmaceuticals Inc: \n* JUNIPER PHARMACEUTICALS OUTLINES STRATEGIC PRIORITIES FOR 2018 AND REPORTS RECENT PORTFOLIO PROGRESS \n* JUNIPER PHARMACEUTICALS INC - ON TRACK TO BE CASH FLOW POSITIVE IN 2018 \n* JUNIPER PHARMACEUTICALS INC - CONTINUED “STRONG” DOUBLE-DIGIT REVENUE GROWTH FOR CRINONE AND JPS EXPECTED IN 2018 \n* JUNIPER - ACTIVE DISCUSSIONS WITH MERCK KGAA TO EXTEND CRINONE PROGESTERONE GEL AGREEMENT ARE PROGRESSING \n* JUNIPER PHARMACEUTICALS INC - PARTNERING OPPORTUNITIES ARE BEING “EXPLORED” FOR JNP-0101, THE OXYBUTYNIN IVR FOR TREATMENT OF OVERACTIVE BLADDER \n* JUNIPER PHARMACEUTICALS - PARTNERING OPPORTUNITIES ARE BEING “EXPLORED” FOR JNP-0301, A NATURAL PROGESTERONE IVR FOR PREVENTION OF PRE-TERM BIRTH Source text for Eikon: Further company coverage:",
    "published": "2018-01-02T23:10:00.000+02:00",
    "crawled": "2018-01-02T23:25:12.000+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "pm",
        "updated",
        "minute",
        "ago",
        "pharmaceutical",
        "outline",
        "strategic",
        "priority",
        "report",
        "recent",
        "portfolio",
        "progress",
        "reuters",
        "staff",
        "jan",
        "reuters",
        "juniper",
        "pharmaceutical",
        "inc",
        "juniper",
        "pharmaceutical",
        "outline",
        "strategic",
        "priority",
        "report",
        "recent",
        "portfolio",
        "progress",
        "juniper",
        "pharmaceutical",
        "inc",
        "track",
        "cash",
        "flow",
        "positive",
        "juniper",
        "pharmaceutical",
        "inc",
        "continued",
        "strong",
        "revenue",
        "growth",
        "crinone",
        "jps",
        "expected",
        "juniper",
        "active",
        "discussion",
        "merck",
        "kgaa",
        "extend",
        "crinone",
        "progesterone",
        "gel",
        "agreement",
        "progressing",
        "juniper",
        "pharmaceutical",
        "inc",
        "partnering",
        "opportunity",
        "explored",
        "oxybutynin",
        "ivr",
        "treatment",
        "overactive",
        "bladder",
        "juniper",
        "pharmaceutical",
        "partnering",
        "opportunity",
        "explored",
        "natural",
        "progesterone",
        "ivr",
        "prevention",
        "birth",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}